PROSTATE CANCER AND PROSTATIC DISEASES

MRI and PSMA PET/CT: Foes or friends for the early detection of prostate cancer?

2026-10-20

Rossano Girometti, Gianluca Giannarini, Alessandro Crestani, Luca Urso

Early apical release versus conventional (non-early apical release) holmium laser enucleation of the prostate: a systematic review and meta-analysis of postoperative urinary incontinence and functional outcomes

2026-10-19

Islam Mansour, Mostafa Shaheen, Aya J. Elkenany, Omar Mohamed Ali, Iyad Walid, Ahmed M. Elshal

Qualitative study on barriers and facilitators to genetic testing in Hispanic patients with prostate cancer

2026-10-17

Perla Chebli, Tatiana Sanchez Nolasco, Mariana Rangel Camacho, Nataliya Byrne, Veda N. Giri, Susan T. Vadaparampil, Stacy Loeb

Cardiometabolic health’s influence on the efficacy of pre-operative hormone therapy for men with localized high-risk prostate cancer

2026-10-15

Mitchell Boshkos, Maria Julia Moura Nascimento Santos, Rebecca S. Tidwell, Neha Venkatesh, Sagar S. Mukhida, Patrick G. Pilie, Sumit K. Subudhi, Paul G. Corn, Ana M. Aparicio, Bilal A. Siddiqui, Debanjan Pain, Efstratios Koutroumpakis, Amado J. Zurita, Daniel E. Frigo, Justin R. Gregg, Christopher J. Logothetis, Johannes F. Fahrmann, Andrew W. Hahn

Metabolic and oncological effects of metformin added to ADT in prostate cancer: systematic review and meta-analysis including STAMPEDE

2026-10-14

Farah Fakhri, Zeid Alkhairi, Talal Sarhan, Gozeel Imran, Lyaba Imran, Raeesah Moola, Radwan Darwish, Abdulrahman Al-Majmuei

Fracture risk and fracture risk factor assessment among men at prostate cancer diagnosis

2026-10-14

Michael J. Shulman, Jeanne A. Darbinian, Malini Chandra, Andrea L. Harzstark, Joan C. Lo

Artificial intelligence in prostate cancer care from performance to clinical integration

2026-10-08

Riccardo Lombardo, Daniele Amparore

How does PSA change after water vapor therapy? A systematic review and meta-analysis

2026-10-06

Pietro Scilipoti, Marie Chicaud, Federico Zorzi, Giuseppe Rosiello, Luca Villa, Marco Bianchi, Giorgio Gandaglia, Alberto Briganti, Francesco Montorsi, Frédéric Panthier, Olivier Traxer, Steeve Doizi, Stessy Kutchukian

Long-term oncologic outcomes of patients with grade group 1 prostate cancer and pT3a disease on final pathology

2026-07-17

Mohamad Watfa

Prostate Cancer and Prostatic Diseases, Published online: 17 July 2026; doi:10.1038/s41391-026-01138-z Long-term oncologic outcomes of patients with grade group 1 prostate cancer and pT3a disease on final pathology]]>

En-bloc vs lobe-by-lobe laser prostatectomy: where do we stand?

2026-06-24

Mahmoud Laymon

Prostate Cancer and Prostatic Diseases, Published online: 24 June 2026; doi:10.1038/s41391-026-01130-7 En-bloc vs lobe-by-lobe laser prostatectomy: where do we stand?]]>

Response to de Riese et al. regarding “methodological and clinical considerations of MRI-based prostate cancer risk calculators”

2026-06-22

Ciarán Courtney O’Toole

Prostate Cancer and Prostatic Diseases, Published online: 22 June 2026; doi:10.1038/s41391-026-01133-4 Response to de Riese et al. regarding “methodological and clinical considerations of MRI-based prostate cancer risk calculators”]]>

Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial

2026-06-20

Quoc-Dien Trinh

Prostate Cancer and Prostatic Diseases, Published online: 20 June 2026; doi:10.1038/s41391-026-01131-6 Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial]]>

Association between concomitant ACEI/ARBs use and survival of patients with prostate cancer receiving abiraterone acetate: A post-hoc analysis of two randomized trials

2026-06-12

Junliang Zhao

Prostate Cancer and Prostatic Diseases, Published online: 12 June 2026; doi:10.1038/s41391-026-01128-1 Association between concomitant ACEI/ARBs use and survival of patients with prostate cancer receiving abiraterone acetate: A post-hoc analysis of two randomized trials]]>

Cytoplasmic versus nuclear localization of androgen receptor splice variant 7 as a predictor of benefit from androgen receptor pathway inhibitors in metastatic castration-resistant prostate cancer (PROPHECY trial)

2026-04-02

Santosh Gupta, Siyuan Guo, Susan Halabi, Chenxi Yu, Hyotae Kim, Jane McKenzie, Daniel J. George, David M. Nanus, Russell Z. Szmulewicz, Daniel C. Danila, Jun Luo, Emmanuel S. Antonarakis, Andrew J. Armstrong

Response to correspondence regarding “The value of micro-ultrasound for prostate cancer screening: a retrospective real-world feasibility study”

2026-03-26

Johann J. Wendler, Jonas Bechstein, Hannes Cash

Prostate Cancer and Prostatic Diseases, Published online: 26 March 2026; doi:10.1038/s41391-026-01112-9 Response to correspondence regarding “The value of micro-ultrasound for prostate cancer screening: a retrospective real-world feasibility study”

Risk factors for incidental prostate cancer following surgery for benign prostatic enlargement: A systematic review and meta-analysis

2026-03-23

Angelo Cormio, Akihiro Matsukawa, Alessandro Dematteis, Ahmed R. Alfarhan, Marcin Miszczyk, Navid Roessler, Abdulrahman S. Alqahtani, Stefano Mancon, Ichiro Tsuboi, Paweł Rajwa, Ugo Giovanni Falagario, Francesca Sanguedolce, Gian Maria Busetto, Carlo Bettocchi, Giuseppe Carrieri, Luigi Cormio, Andrea Benedetto Galosi, David D’Andrea, Takahiro Kimura, Shahrokh F. Shariat

Prostate Cancer and Prostatic Diseases, Published online: 23 March 2026; doi:10.1038/s41391-026-01108-5 Risk factors for incidental prostate cancer following surgery for benign prostatic enlargement: A systematic review and meta-analysis